Taub Robert

Avg. Two Year Performance

No purchase track record
17% Avg. Sale Return
8% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return26%42%66%0%0%
Purchase Success Rate1 of 11 of 11 of 10 of 10 of 1
Average Sale Return(11%)(28%)(8%)(22%)17%
Sale Success Rate0 of 10 of 10 of 10 of 11 of 1
Drugs » Biotechnology

Chief Executive Officer, Director:

Holdings: 2.84M shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Other » Other

Director:

Holdings: shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--